Jacob E Møller

Jacob E Møller

Clinical Professor, Chief Physician, PhD, Research Director

Odense University Hospital, Denmark

  • Radcliffe

Expertise

InterventionMI/ACS

Media

ESC 2018: Why use percutaneous ventricular assist devices?

Nicolas M Van Mieghem, Ralf Westenfeld, Jacob E Møller, et al

Watch time: 6m 34s

Articles by Jacob E Møller, Clinical Professor, Chief Physician, PhD, Research Director

A21 - Impact of Concomitant Vasoactive Treatment in Active Left Ventricular Unloading in Cardiogenic Shock

Nanna Junker Udesen, Jacob E Møller, Matias Greve Lindholm, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A21.

DOI:

https://doi.org/10.15420/icr.2019.14.3.S1
A15 - Impella Mechanical Circulatory Support for Takotsubo Syndrome with Shock

L Christian Napp, Jacob E Møller, Federico Pappalardo, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A15.

DOI:

https://doi.org/10.15420/icr.2019.14.3.S1
A13 - A Matched-pair Analysis of the Association Between Early Use of Impella CP or IABP and 30-day Mortality in Patients with Acute MI and Cardiogenic Shock

Ole KL Helgestad, Jakob Josiassen, Christian Hassager, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3 Suppl 1):A13.

DOI:

https://doi.org/10.15420/icr.2019.14.3.S1
Comparative Haemodynamic Response to Impella Versus Extracorporeal Membrane Oxygenation Support in a Porcine Cardiogenic Shock Model

Jacob E Møller,

Published:

Citation: Interventional Cardiology Review 2017;12(2 Suppl 2):10-11.

DOI:

https://doi.org/10.15420/icr.2017.12.2.S2